Multiple myeloma trials in United States

In United States 297 Also abroad 703

297 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Where
Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Houston, Salt Lake City
Age
13 years and over
People
100
Run by
Newave Pharmaceutical Inc
See details and how to joinNCT04771572
No phaseTaking people
A Dietary Study for People With Multiple Myeloma
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
Age
18 years and over
People
220
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07226609
No phaseTaking people
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
Where
Miami
Age
18 years and over
People
120
Run by
University of Miami
See details and how to joinNCT07446777
Phase 1Taking people
Pilot Imaging Study of Leukemia
Where
Atlanta, Oklahoma City, Washington D.C.
Age
4 years to 80 years
People
60
Run by
University of Oklahoma
See details and how to joinNCT03633955
Phase 3Taking people
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Where
St Louis
Age
18 years and over
People
60
Run by
St. Louis University
See details and how to joinNCT03823534
Phase 2Taking people
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Where
Austin, Cincinnati, Columbia, Denver, Elizabeth City, Eugene, Fairfax, Lake Mary, Minneapolis, Nashville, Newark, Roanoke, San Antonio, Tucson, Tyler
Age
18 years and over
People
100
Run by
SCRI Development Innovations, LLC
See details and how to joinNCT05972135
Phase 3Taking people
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Where
Ann Arbor, Atlanta, Aurora, Austin, Beverly Hills, Billings, Charlotte, Columbus, Detroit, Englewood, Fairfax, Hackensack, Kingwood, Lady Lake, Mobile, New York, Pasadena, Pembroke Pines, Phoenix, Portland, Providence, Puyallup, Saint Augustine, San Antonio, Stony Brook, Tyler, Washington D.C., Winston-Salem, Worcester
Age
18 years and over
People
520 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00
No phaseTaking people
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Where
Boston
Age
18 years and over
People
90
Run by
Massachusetts General Hospital
See details and how to joinNCT05646576
No phaseTaking people
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Where
Atlanta, Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
Age
18 years and over
People
180
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05640843
No phaseTaking people
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Where
Winston-Salem
Age
18 years to 120 years
People
2,000
Run by
Wake Forest University Health Sciences
See details and how to joinNCT01890486
No phaseTaking people
Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma
Where
Rochester
Age
65 years and over
People
25
Run by
Mayo Clinic
See details and how to joinNCT06145581
Phase 1Taking people
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
Where
Boston
Age
18 years and over
People
25
Run by
Massachusetts General Hospital
See details and how to joinNCT07032714
No phaseTaking people
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
Where
Miami
Age
18 years and over
People
1,000
Run by
University of Miami
See details and how to joinNCT05361694
No phaseTaking people
Study of CAR-T Therapy in Older Patients
Where
New York
Age
60 years and over
People
154
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04300998
Phase 1/2Taking people
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
Where
Houston
Age
18 years and over
People
42
Run by
The Methodist Hospital Research Institute
See details and how to joinNCT06536413
Phase 1Taking people
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Where
Atlanta, Boston, Chapel Hill, Chicago, Miami, Milwaukee, Nashville, Palo Alto, Richmond, The Bronx
Age
18 years and over
People
200 worldwide
Run by
Ichnos Sciences SA
See details and how to joinNCT05862012 · EU 2023-507071-21-01
No phaseTaking people
Survivors Uniting for Remote Guided Exercise
Where
Fort Collins
Age
18 years and over
People
300
Run by
Colorado State University
See details and how to joinNCT07290309
Phase 1Taking people
Hypofractionation (Radiation) Trial for Multiple Myeloma
Where
Chicago
Age
18 years and over
People
30
Run by
University of Chicago
See details and how to joinNCT06270888
Phase 1Taking people
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Where
Hackensack, Jacksonville, Philadelphia, Phoenix, Rochester
Age
18 years and over
People
87 worldwide
Run by
Sanofi
See details and how to joinNCT06630806
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Baltimore, Boston, Buffalo, Chapel Hill, Charleston, Charlottesville, Chicago, Columbus, Denver, Durham, Eugene, Fairfax, Houston, Miami, Morristown, Nashville, New Brunswick, Newport Beach, New York, Norfolk, Palo Alto, Philadelphia, Pittsburgh, Salt Lake City, Tampa, Washington D.C., Winston-Salem
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
No phaseTaking people
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Where
Columbus
Age
18 years and over
People
5,000
Run by
Ohio State University Comprehensive Cancer Center
See details and how to joinNCT01408225
Phase 1Taking people
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Where
Birmingham, Boston, Denver, Duarte, Nashville, New Haven, New York, San Francisco, Seattle, Stanford, Tampa
Age
18 years and over
People
187 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06153251 · EU 2023-506003-26-00
Phase 1Taking people
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Where
San Francisco
Age
18 years and over
People
32
Run by
Alfred Chung, MD
See details and how to joinNCT06348108
No phaseEnrolling by invitation
Long-Term Follow-up Study
Where
Atlanta, Augusta, Birmingham, Charlotte, Cincinnati, Cleveland, Dallas, Denver, Gilbert, Hackensack, Houston, Iowa City, Irvine, La Jolla, Lexington, Louisville, Miami, Milwaukee, Morristown, Nashville, New York, Orlando, Philadelphia, Richmond, Salt Lake City, Scottsdale, Seattle, The Bronx
Age
18 years and over
People
150
Run by
Caribou Biosciences, Inc.
See details and how to joinNCT05332054
Early phase 1Taking people
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Where
Augusta
Age
18 years to 80 years
People
30
Run by
Augusta University
See details and how to joinNCT06142396